Zoetis (ZTS) Other Non-Current Liabilities (2012 - 2026)

Zoetis' (ZTS) quarterly Other Non-Current Liabilities came in at $281.0 million in Q1 2026, up 1.44% year-on-year from $277.0 million in Q1 2025, and up 12.4% on a QoQ basis from $250.0 million in Q4 2025.

Zoetis (ZTS) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Other Non-Current Liabilities data on file, last reported at $281.0 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 1.44% year-over-year to $281.0 million in Q1 2026; TTM through Mar 2026 was $281.0 million, a 1.44% increase from a year earlier, with the FY2025 full-year figure at $250.0 million, down 8.09% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $281.0 million, up from $250.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for ZTS reached as high as $281.0 million in Q1 2026 and fell as low as $216.0 million in Q1 2023.
  • Historically, Other Non-Current Liabilities has averaged $249.5 million across 5 years, with a median of $250.0 million in 2025.
  • Across the five-year window, Other Non-Current Liabilities declined 10.73% in 2022 and advanced 23.42% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $258.0 million in 2022, then decreased by 8.14% to $237.0 million in 2023, then grew by 14.77% to $272.0 million in 2024, then dropped by 8.09% to $250.0 million in 2025, then gained by 12.4% to $281.0 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $281.0 million in Q1 2026, $250.0 million in Q4 2025, and $264.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 281.00 Mn
Dec 31, 2025 250.00 Mn
Sep 30, 2025 264.00 Mn
Jun 30, 2025 274.00 Mn
Mar 31, 2025 277.00 Mn
Dec 31, 2024 272.00 Mn
Sep 30, 2024 274.00 Mn
Jun 30, 2024 222.00 Mn
Mar 31, 2024 228.00 Mn
Dec 31, 2023 237.00 Mn
Sep 30, 2023 259.00 Mn
Jun 30, 2023 217.00 Mn
Mar 31, 2023 216.00 Mn
Dec 31, 2022 258.00 Mn
Sep 30, 2022 239.00 Mn
Jun 30, 2022 233.00 Mn
Mar 31, 2022 241.00 Mn
Dec 31, 2021 239.00 Mn
Sep 30, 2021 251.00 Mn
Jun 30, 2021 261.00 Mn